SELLAS Life Sciences Group, Inc. SLS Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s retained earnings?
- SELLAS Life Sciences Group, Inc. (SLS) reported retained earnings of -$283.4M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s retained earnings changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s retained earnings decreased by 11.6% year-over-year, from -$253.94M to -$283.4M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s retained earnings has grown at a 18.5% compound annual growth rate (CAGR), from -$117.9M to -$274.99M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.